BiomX Inc. — Director's Dealing 2025

Apr 21, 2025

SEC Form 4/A — Form 4/A

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2025-04-14

Reporting Person: Williams Eddie (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-14	Common Stock Options - right to Buy	$0.538	A	17600	Acquired	2035-04-14	Common Stock (17600)	Direct

Footnotes

F1: The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.